Children's Hospital Medical Center, Cincinnati, proposes an exploratory research center in juvenile rheumatic disease aimed at developing the resources and collaborative relationships needed for establishing a research center under the Multipurpose Arthritic and Musculoskeletal Disease Center (MAMDC) program. The exploratory center will have two major research components: (1) education, epidemiology, and health services research (EEHSR); and (2) biomedical studies (BIOMED). This comprehensive program will advance new applied clinical research and promote innovative approaches to laboratory investigations in the field of juvenile rheumatic disease. The EEHSR component proposes two pilot projects: (1) Long-term disease outcome among patients with juvenile rheumatoid arthritis (JRA); and (2) Bone mineralization in JRA. The BIOMED component proposes three additional pilot projects: (3) Tumor necrosis factor in JRA; (4) The role of superantigen in Kawasaki's disease; and (5) Application of human genome methodology to JRA. Eight additional developmental and feasibility studies described in this proposal may be either activated during the proposed funded period or incorporated into an evolving MAMDC application. An Administrative and Planning Core will provide support services and executive leadership to the pilot projects and to the developing MAMDC through a number of subcores and resources: (1) Executive- Administrative-Planning Subcore; (2) Epidemiology-Biostatistical-Databank Subcore; (3) Patient Assessment Subcore; (4) Tissue Bank Resource; and (5) Molecular and Cellular Immunology Laboratory Resource. Through the proposed funded period an Executive and Planning Committee will develop an application to be submitted to the NIH under the MAMDC program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Exploratory Grants (P20)
Project #
1P20AR042632-01
Application #
3100536
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1993-09-30
Project End
1996-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Thornton, Sherry; Sowders, Dawn; Aronow, Bruce et al. (2002) DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 105:155-68
Scola, Michael P; Thompson, Susan D; Brunner, Hermine I et al. (2002) Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 29:369-78
Thornton, S; Kuhn, K A; Finkelman, F D et al. (2001) NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2. Eur J Immunol 31:3355-60
Griffin, T A; Slack, J P; McCluskey, T S et al. (2000) Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. Mol Cell Biol Res Commun 3:212-7
Thornton, S; Boivin, G P; Kim, K N et al. (2000) Heterogeneous effects of IL-2 on collagen-induced arthritis. J Immunol 165:1557-63
Lovell, D J; Giannini, E H; Reiff, A et al. (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-9
Hashkes, P J; Balistreri, W F; Bove, K E et al. (1999) The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 134:47-52
Lovell, D J; Lindsley, C B; Rennebohm, R M et al. (1999) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis D Arthritis Rheum 42:2213-9
Murray, K J; Grom, A A; Thompson, S D et al. (1998) Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 25:1388-98
Sleight, B J; Prasad, V S; DeLaat, C et al. (1998) Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 22:375-80

Showing the most recent 10 out of 32 publications